Patents Assigned to WUHAN HEALTHGEN BIOTECHNOLOGY CORP
  • Patent number: 11913002
    Abstract: Provided is a modified rice endosperm-specific promoter, which has a sequence as shown in any one of SEQ ID. NOs. 1 to 5. The EnhGt13? promoter as shown in SEQ ID NO. 2 drives GUS activity in vitro and mediates the expression of foreign proteins in rice endosperm cells, which is significantly higher than that of the unmodified Gt13? promoter. The promoter can be applied to the fields of improving seed quality, molecular pharming, etc.
    Type: Grant
    Filed: August 17, 2021
    Date of Patent: February 27, 2024
    Assignee: WUHAN HEALTHGEN BIOTECHNOLOGY CORP.
    Inventors: Daichang Yang, Kunpeng Li
  • Patent number: 10730926
    Abstract: Disclosed is a chromatographic method for isolating and purifying high-purity recombined human serum albumin, comprising: conducting cation-exchange chromatography on recombined human serum albumin, and adding alcohol to a buffer solution to remove endotoxin, so as to obtain a primary product I; under binding conditions, conducting anion/hydrophobic composite resin exchange chromatography on the primary product I to obtain an intermediate product II; conducting hydrophobic chromatography on the intermediate product II to obtain the target product, the purified high-purity recombined human serum albumin. The purity of the recombined human serum albumin obtained by isolating and purifying with the chromatographic method of the present invention is greater than 99.9999%, and the content of the endotoxin meets the criteria stipulated by Chinese pharmacopoeia.
    Type: Grant
    Filed: May 9, 2013
    Date of Patent: August 4, 2020
    Assignee: WUHAN HEALTHGEN BIOTECHNOLOGY CORP
    Inventors: Daichang Yang, Bo Shi, Qianni Shi, Jiquan Ou, Jingru Liu
  • Publication number: 20150329618
    Abstract: Disclosed is a chromatographic method for isolating and purifying high-purity recombined human serum albumin, comprising: conducting cation-exchange chromatography on recombined human serum albumin, and adding alcohol to a buffer solution to remove endotoxin, so as to obtain a primary product I; under binding conditions, conducting anion/hydrophobic composite resin exchange chromatography on the primary product I to obtain an intermediate product II; conducting hydrophobic chromatography on the intermediate product II to obtain the target product, the purified high-purity recombined human serum albumin. The purity of the recombined human serum albumin obtained by isolating and purifying with the chromatographic method of the present invention is greater than 99.9999%, and the content of the endotoxin meets the criteria stipulated by Chinese pharmacopoeia.
    Type: Application
    Filed: May 9, 2013
    Publication date: November 19, 2015
    Applicant: WUHAN HEALTHGEN BIOTECHNOLOGY CORP
    Inventors: Daichang YANG, Bo SHI, Qianni SHI, Jiquan OU, Jingru LIU